Development of a Suspicion Index to aid diagnosis of Niemann-Pick disease type C

Neurology

Volumn 78, Issue 20, 2012, Pages 1560-1567

  Wijburg, F A ^a   Sedel, F ^b   Pineda, M ^c   Hendriksz, C J ^d   Fahey, M ^e   Walterfang, M ^f   Patterson, M C ^g   Wraith, J E ^h   Kolb, S A ⁱ  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MAYO CLINIC   (United States)

^h ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

ⁱ ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL EQUIPMENT; AUSTRALIA; CATAPLEXY; CHOLESTASIS; COGNITIVE DEFECT; DEMENTIA; EUROPE; FEMALE; GAZE PARALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN JAUNDICE; NIEMANN PICK DISEASE; PARENT; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SIBLING; SPLENOMEGALY; SUSPICION INDEX TOOL; ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL TRIAL; FAMILY HEALTH; INFANT; INTERNATIONAL COOPERATION; MENTAL DISEASE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STANDARD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; EUROPE; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INTERNATIONAL COOPERATION; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROLOGIC EXAMINATION; NIEMANN-PICK DISEASE, TYPE C; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84863594896     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182563b82     Document Type: Article

References (16)

1. Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis 2010;5:16.
2. Vanier MT. Phenotypic and genetic heterogeneity in Niemann-Pick disease type C: Current knowledge and practical implications. Wien Klin Wochenschr 1997;109:68-73.
3. Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269-281.
4. Patterson MC, Vanier MT, Suzuki K, et al. Niemann-Pick disease type C: A lipid trafficking disorder. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw Hill; 2001:3611-3634.
5. Wraith JE, Baumgartner MR, Bembi B, et al. Recommendations on the diagnosis and management of Niemann- Pick disease type C. Mol Genet Metab 2009;98:152-165.
6. Spiegel R, Raas-Rothschild A, Reish O, et al. The clinical spectrum of fetal Niemann-Pick type C. Am J Med Genet A 2009;149A:446-450.
7. Vanier MT, Wenger DA, Comly ME, Rousson R, Brady RO, Pentchev PG. Niemann-Pick disease group C: Clinical variability and diagnosis based on defective cholesterol esterification: A collaborative study on 70 patients. Clin Genet 1988;33:331-348.
8. Trendelenburg G, Vanier MT, Maza S, et al. Niemann- Pick type C disease in a 68-year-old patient. J Neurol Neurosurg Psychiatry 2006;77:997-998.
9. Sedel F. Clinical diagnosis of the adult form of Niemann- Pick type C disease [in French]. Arch Pediatr 2010; 17(suppl 2):S50-S53.
10. Pentchev PG, Comly ME, Kruth HS, et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci USA 1985;82:8247-8251.
11. Park WD, O'Brien JF, Lundquist PA, et al. Identification of 58 novel mutations in Niemann-Pick disease type C: Correlation with biochemical phenotype and importance of PTC1- like domains in NPC1. Hum Mutat 2003;22:313-325.
12. Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 1997;277:228-231.
13. Jiang X, Sidhu R, Porter FD, et al. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 2011;52: 1435-1445.
14. Summary of the European Public Assessment Report (EPAR) for Zavesca (miglustat). Available at: Http://www.ema.europa.eu/ema/index.jsp?curl-pages/ medicines/ human/medicines/000435/human-med-001171.jsp&murl-menus/medicines/ medicines.jsp&mid-WC0b01ac058001d124&jsenabled-true. Accessed January 17, 2011.
15. Moons KGM, Harrell FE, Steyerberg EW. Should scoring rules be based of odds ratios or regression coefficients? J Clin Epidemiol 2002;55:1054-1055.
16. Iwi G, Millard RK, Palmer AM, Preece AW, Saunders M. Bootstrap resampling: A powerful method of assessing confidence intervals for doses from experimental data. Phys Med Biol 1999;44:N55-N62.